Starting in July 2017, participating clinics and DVSPs reported quarterly data on patients screened using the HARK tool and response services offered by clinic staff to patients who screened positive. Final quarterly report data was collected in October, 2018.
HARK Screening Data
Over the course of the project, our sites served over 42,000 women and screened over 10,000 of those women (or 24%) for IPV with the HARK screening tool. The number of patients screened across all sites increased through the first year while implementation was being rolled out, the number of patients screened peaked between January and April of 2018. The percentage of patients who screened positive for experiencing IPV in the previous 12 months remained around 5- 6% throughout the duration of data collection.
Response Services Offered
Of the patients who screened positive across all healthcare sites, 51% chose to meet with a trained IPV Responder while 49% elected not to meet with an IPV Responder. 96% of those who met with an IPV Responder were offered a warm referral (facilitated phone call) to the partner DVSP and 14% ended up making a phone call to a DVSP.
